This HTML5 document contains 50 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n15http://linked.opendata.cz/resource/mesh/concept/
n13http://linked.opendata.cz/resource/drugbank/drug/DB04660/identifier/chebi/
n17http://bio2rdf.org/drugbank:
n6http://linked.opendata.cz/resource/drugbank/drug/DB04660/identifier/pdb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB04660/identifier/kegg-compound/
admshttp://www.w3.org/ns/adms#
n7http://linked.opendata.cz/resource/drugbank/drug/DB04660/identifier/pubchem-compound/
n9http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://linked.opendata.cz/resource/drugbank/drug/DB04660/identifier/pubchem-substance/
owlhttp://www.w3.org/2002/07/owl#
n14http://linked.opendata.cz/ontology/mesh/
n3http://linked.opendata.cz/ontology/drugbank/
n10http://linked.opendata.cz/resource/drugbank/drug/DB04660/identifier/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04660
rdf:type
n3:Drug
n3:description
A component of phosphatidylcholines (lecithins), in which the two hydroxy groups of glycerol are esterified with fatty acids. (From Stedman, 26th ed) It counteracts the effects of urea on enzymes and other macromolecules. [PubChem]
n3:generalReferences
# Ferraro L, Tanganelli S, Marani L, Bianchi C, Beani L, Siniscalchi A: Evidence for an in vivo and in vitro modulation of endogenous cortical GABA release by alpha-glycerylphosphorylcholine. Neurochem Res. 1996 May;21(5):547-52. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/8726961
n3:group
experimental
owl:sameAs
n9:DB04660 n17:DB04660
dcterms:title
Glycerylphosphorylcholine
adms:identifier
n6:CH5 n7:439285 n10:DB04660 n11:C00670 n12:46508680 n13:16870
n3:synonym
L-alpha-Glycerylphosphorylcholine 2-{[(2R)-2,3-dihydroxypropoxy](hydroxy)phosphoryloxy}-N,N,N-trimethylethanaminium SN-glycero-3-phosphocholine L-alpha-Glycerophosphorylcholine L-alpha-Glycerophosphocholine Choline Alfoscerate glycero-3-phosphocholine
n3:synthesisReference
Carlo Scolastico, Giovanni Tronconi, "Diacyl derivatives of glycerylphosphorylcholine, their preparation, and antihyperlipidemic compositions." U.S. Patent US4699901, issued October 13, 1987.
n14:hasConcept
n15:M0009450
n3:IUPAC-Name
n4:271B47C0-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B47C6-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B47C5-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B47C2-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B47C3-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B47C4-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B47BE-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B47BC-363D-11E5-9242-09173F13E4C5 n4:271B47BF-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B47BD-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B47CC-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B47CD-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B47C7-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B47C8-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B47CA-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B47C9-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B47CB-363D-11E5-9242-09173F13E4C5
n3:affectedOrganism
Humans and other mammals
n3:casRegistryNumber
563-24-6
n3:Bioavailability
n4:271B47D2-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B47D4-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B47D5-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B47D1-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B47D0-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B47D3-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B47C1-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B47CE-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B47CF-363D-11E5-9242-09173F13E4C5